- Home
- VINP vs VSTM Comparison
VINP vs VSTM Comparison
Compare VINP & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VINP | VSTM |
|---|---|---|
| Founded | 2009 | 2010 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 620.4M | 731.8M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | VINP | VSTM |
|---|---|---|
| Price | $10.85 | $7.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $14.02 | ★ $14.67 |
| AVG Volume (30 Days) | 47.9K | ★ 2.0M |
| Earning Date | 11-12-2026 | 11-03-2026 |
| Dividend Yield | ★ 5.78% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,914,000.00 |
| Revenue This Year | $17.76 | $276.56 |
| Revenue Next Year | $13.10 | $55.57 |
| P/E Ratio | $24.41 | ★ N/A |
| Revenue Growth | N/A | ★ 209.14 |
| 52 Week Low | $9.13 | $3.43 |
| 52 Week High | $13.61 | $10.82 |
Technical Indicators
Market Signals| Indicator | VINP | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 75.15 | 52.76 |
| Support Level | $9.36 | $7.29 |
| Resistance Level | $10.88 | $7.86 |
| Average True Range (ATR) | 0.31 | 0.46 |
| MACD | 0.15 | -0.05 |
| Stochastic Oscillator | 99.42 | 40.00 |
Price Performance
Historical ComparisonAbout VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.